In July 2021, we began highlighting some of the incredible women leading our research initiatives at the McKnight Brain Institute. Check out some of our fearless leaders below!
Dr. Maciel is a neurointensivist with dedicated training in EEG monitoring in critically ill patients. Dr. Maciel’s areas of scientific focus include neuroprognostication, secondary brain injury mechanisms while understanding the impact of cortical electrical phenomena after acute brain injuries, novel therapeutic approaches to status epilepticus and acute pain, and the critical care management of the potential organ donor.
Dr. Armstrong’s research focuses on the lived experience of disease for individuals with Lewy body dementia and their families, ranging from patient and caregiver priorities for care to hospital outcomes to end-of-life experiences.
Dr. Katharina Busl is the medical director of the UF Health Shands Neurointensive Care Unit and UF’s neurocritical care division chief. Her research interests center around care innovations and quality of care in neurocritical care.
Dr. Nixon is a clinical researcher in the area of substance abuse and dependence. Due to the complex nature of substance abuse, her work uses comprehensive behavioral assessments including neuropsychological testing, brain electrophysiology, and clinical research interviews.
Dr. Price’s research is devoted to studying the neuropsychology of older adults with and without dementia and neuroanatomical dissociates on older adults’ cognitive functioning and cognitive change.
Dr. Mathews is a renowned clinician and translational researcher in the areas of obsessive-compulsive disorder, tics and anxiety disorders.
Dr. Tansey’s research explores the role and regulation of neuroinflammatory and immune system responses in modulating the gene-environment interactions that determine risk for development and progression of neurodegenerative and neuropsychiatric disease.
Dr. Burke’s research investigates mechanisms of cognition and determining how diet and metabolic function can increase resilience to memory loss in aging and disease. To answer these questions, her lab integrates data across multiple levels of analysis that includes neurophysiology, gene expression, anatomy and behavioral assays.
Dr. Cruz-Almeida’s research is focused on understanding age-related pain perception and modulation in humans. Her research examines nervous system factors contributing to the observed inter-individual differences in pain phenotypes and its functional consequences including cognitive and mobility impairments.
Dr. Ranum’s research focuses on the role of Repeat Associated Non-ATG (RAN) translation, RNA gain of function and protein gain of function in repeat expansion disorders including amyotrophic lateral sclerosis (ALS), spinocerebellar ataxia (SCA) types 5 and 8, myotonic dystrophy (DM) types 1 and 2 and Huntington’s disease (HD).
Dr. Bussing currently holds the position of professor and chief of faculty development in the department of psychiatry at UF. Her research expertise spans mental health services, measure development, pharmaco-epidemiology, psychotherapy intervention, and clinical pharmacology trials research.
Dr. Jennifer Bizon is a professor and chair of the department of neuroscience. Her research is broadly focused on understanding brain aging and its implications for cognitive function. She participates in the training of medical students, graduate students, undergraduates, and postdoctoral fellows.